Results 101 to 110 of about 11,297 (212)

The near disappearance of fetal hydrops in relation to current state‐of‐the‐art management of red cell alloimmunization

open access: yesPrenatal Diagnosis, 2018
In this study, we aim to evaluate trends in the condition of fetuses and neonates with hemolytic disease at the time of first intrauterine transfusion (IUT) and at birth, in relation to routine first‐trimester antibody screening, referral guidelines, and
C. Zwiers   +5 more
semanticscholar   +1 more source

Monitoring and Management of Hemolytic Disease of the Fetus and Newborn Based on an International Expert Delphi Consensus [PDF]

open access: yes
: The study aimed to develop structured, expert-based clinical guidance on the prenatal and postnatal management of hemolytic disease of the fetus and newborn.
Angeles SANCHEZ-DURAN   +113 more
core   +1 more source

Alloimmunization prevents the migration of transfused indium-111- labeled granulocytes to sites of infection [PDF]

open access: bronze, 1983
JP Dutcher   +6 more
openalex   +1 more source

Prevention of refractoriness and HLA-alloimmunization using filtered blood products [PDF]

open access: bronze, 1988
Irena Sniecinski   +3 more
openalex   +1 more source

Frequency of irregular red cell alloantibodies in patients with thalassemia major: a bicenter study [PDF]

open access: yes, 2005
Objective: To provide frequency and distribution pattern of various types of irregular red cell alloantibodies in patients with thalassemia major. Methods: This is a descriptive study conducted at two centers from January to December 2001.
Adil, Salman   +5 more
core   +1 more source

Correlation between blood group and autoantibodies formation in multi-transfused thalassaemia patients [PDF]

open access: yes
Background: Thalassemia is a prevalent genetic disorder of hemoglobin synthesis, characterized by reduced production or absence of one or more globin chains, requiring frequent blood transfusions that can lead to complications such as autoantibody ...
Al-Mamun, A. B. M.   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy